An observational prospective study to understand the usage pattern of Ticagrelor with ACS (acute coronary syndrome)

Trial Identifier: D5130R00029
Sponsor: AstraZeneca
NCTID:: NCT02408224
Start Date: April 2015
Primary Completion Date: June 2017
Condition: Coronary Artery Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
India, Delhi Delhi, India
INDIA, Andhra Pradesh Hyderabad, Andhra Pradesh, INDIA
INDIA, Andhra Pradesh Vijayawada, Andhra Pradesh, INDIA
INDIA, Bihar Patna, Bihar, INDIA
INDIA, Delhi New Delhi, Delhi, INDIA
INDIA, Gujarat Ahmedabad, Gujarat, INDIA
INDIA, Gujarat Rajkot, Gujarat, INDIA
INDIA, Gujarat Surat, Gujarat, INDIA
INDIA, Gujarat Vadodara, Gujarat, INDIA
INDIA, Haryana Gurgaon, Haryana, INDIA
INDIA, Jammu and Kashmir Srinagar, Jammu and Kashmir, INDIA
INDIA, Karnataka Bangalore, Karnataka, INDIA
INDIA, Karnataka Bengaluru, Karnataka, INDIA
INDIA, Karnataka Mysore, Karnataka, INDIA
INDIA, Kerala Kolenchery, Kerala, INDIA
INDIA, Kerala Thrissur, Kerala, INDIA
INDIA, Maharashtra Mumbai, Maharashtra, INDIA
INDIA, Maharashtra Nasik, Maharashtra, INDIA
INDIA, Maharashtra Pune, Maharashtra, INDIA
INDIA, New Delhi Delhi, New Delhi, INDIA
INDIA, Odisha Bhubaneswar, Odisha, INDIA
INDIA, Punjab Ludhiana, Punjab, INDIA
INDIA, Punjab Mohali, Punjab, INDIA
INDIA, Rajasthan Jaipur, Rajasthan, INDIA
INDIA, Tamil Nadu Chennai, Tamil Nadu, INDIA
INDIA, Tamil Nadu Coimbatore, Tamil Nadu, INDIA
INDIA, Tamil Nadu Madurai, Tamil Nadu, INDIA
INDIA, Telangana Hyderabad, Telangana, INDIA
INDIA, Uttar Pradesh Lucknow, Uttar Pradesh, INDIA
INDIA, Uttar Pradesh Noida, Uttar Pradesh, INDIA
INDIA, West Bengal Durgapur, West Bengal, INDIA
INDIA, West Bengal Kolkata, West Bengal, INDIA